Clinical trials
2 active studies led by vTv Therapeutics, of 14 in all
Source: ClinicalTrials.gov, Studies with vTv Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show vTv Therapeutics in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by vTv Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: SEC EDGAR, Company filings, CIK 1641489. Retrieved 13 Nov 2026.
2 active studies led by vTv Therapeutics, of 14 in all
Source: ClinicalTrials.gov, Studies with vTv Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1641489.
Studies vTv Therapeutics leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with vTv Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show vTv Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets vTv Therapeutics is in.
Stories on the topics vTv Therapeutics works in.
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Atrial fibrillation raises stroke risk about five-fold. Holter monitors, patches, implants and smartwatches…
Read
Over 9.5 million people live with type 1 diabetes and need insulin every day. How delivery devices are…
Read